What is Citius Oncology, Inc.'s risk-free rate?

Citius Oncology, Inc. (CTOR) reported risk-free rate of 4.7% in Q3 2024.

What does risk-free rate mean?

The risk-free interest rate used as a key assumption in the Black-Scholes or similar option-pricing models to value employee stock-based compensation. This rate is typically based on the yield of government bonds with a maturity matching the expected term of the awards.

Citius Oncology, Inc. CTOR Risk-free rate

Risk-free rate at other companies

Utah Medical ProductsUTMD

3.8%-0.5pp

AshlandASH

4.3%-0.3pp

Boston BeerSAM

3.4%-0.9pp

Bicara TherapeuticsBCAX

3.8%—

Richardson ElectronicsRELL

4.2%+0.2pp

AIR

Air TAIRT

4.1%+3.2pp

Other financials

Income statement

See full

Revenue$1.7M—

Gross profit$1.3M—

Operating income-$28.6M-283%

Net income-$26.6M-244%

EPS (diluted)-$0.27-145%

Balance sheet

See full

Cash & equivalents$2.6M+2,350,466%

Total equity$35.3M-1.0%

Total assets$100.7M+10.1%

Cash flow

See full

Operating cash flow-$3.8M-179%

Valuation

See full

Market cap$60.45M-74.7%

Returns & leverage

See full

Return on equity-119.9%+46.7pp

Current ratio0.5×+0.1×

Where this comes from

Reported directly by Citius Oncology, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate.

The official record: Citius Oncology, Inc.’s 10-K, filed December 23, 2025, on SEC EDGAR. View the filing →

Ask your AI about Citius Oncology, Inc.'s risk-free rate.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Citius Oncology, Inc.'s risk-free rate?: Citius Oncology, Inc. (CTOR) reported risk-free rate of 4.7% in Q3 2024.
What does risk-free rate mean?: The risk-free interest rate used as a key assumption in the Black-Scholes or similar option-pricing models to value employee stock-based compensation. This rate is typically based on the yield of government bonds with a maturity matching the expected term of the awards.